27.08.2013 Views

Electrostatic Similarity

Electrostatic Similarity

Electrostatic Similarity

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Electrostatic</strong> <strong>Similarity</strong><br />

Anthony Nicholls<br />

Cup VII, Santa Fe, March 7 th 2006


Outline<br />

• Introduction to EON<br />

• EON Joy<br />

• EON Despair<br />

• What EON is and isn’t<br />

• Mutant EONs<br />

• Fast EON. No, really.<br />

• The Meaning of EON


Shape & <strong>Electrostatic</strong>s<br />

m<br />

field<br />

potential<br />

n<br />

field<br />

steric<br />

dv<br />

dv<br />

m<br />

n<br />

=<br />

=<br />

!<br />

=<br />

"<br />

!<br />

=<br />

#<br />

$<br />

$<br />

%<br />

&<br />

%<br />

%<br />

&<br />

&<br />

space<br />

all<br />

2<br />

2<br />

1<br />

2<br />

space<br />

all<br />

2<br />

2<br />

1<br />

2<br />

)<br />

(<br />

)<br />

(<br />

ance<br />

Dist<br />

tic<br />

Electrosta<br />

Shape<br />

/<br />

, =<br />

!<br />

"<br />

ROCS<br />

EON


Shape/<strong>Electrostatic</strong> Tanimoto<br />

Overlap(<br />

A,<br />

B)<br />

Overlap(<br />

A,<br />

A)<br />

+ Overlap(<br />

B,<br />

B)<br />

! Overlap(<br />

A,<br />

B)<br />

• Larger Tanimoto = More similar = Better<br />

• Smaller Tanimoto = Less similar = Worse<br />

• Range= [0,1]<br />

• Value understood, e.g. ST>0.75 = similar shape


<strong>Electrostatic</strong> Tanimoto<br />

ET>0.6


• We Believe Steve<br />

• SAESAR:<br />

– COX2, Dopamine<br />

• Charged Ligands<br />

– PT1B kinase<br />

EON Joy<br />

– Thymidine Synthetase<br />

• BioIsosteres


Schnecke & Boström, 2006<br />

Cilomilast vs. Piclamilast


Steve Muchmore and the How Not to Get Published<br />

ST=0.84<br />

ET=0.56<br />

CT=<br />

HTS<br />

6nM<br />

3M V-HTS<br />

2-Step Synthesis<br />

2nM<br />

ROCS+EON


Shape Tanimoto<br />

0.2 0.4 0.6 0.8<br />

Decoys plus Highly Actives<br />

Shape and <strong>Electrostatic</strong> Tanimoto Similarities to Cox Crystal Ligand<br />

-0.2 0.0 0.2 0.4 0.6<br />

<strong>Electrostatic</strong> Tanimoto<br />

Wombat Decoys<br />

43 highly active<br />

Xray structure Cox2: SC-558


Shape Tanimoto<br />

0.0 0.2 0.4 0.6 0.8 1.0<br />

Dopamine D2 Cluster 1 Centroid vs Highly Actives and Wombat Decoys<br />

3 active structures<br />

ET<br />

Dopamine Active<br />

Wombat Decoys<br />

Centroid<br />

-0.2 0.0 0.2 0.4 0.6 0.8 1.0


Two Thrombin Inhibitors:<br />

Shape Tanimoto 0.51


Two Thrombin Inhibitors:<br />

<strong>Electrostatic</strong> Tanimoto 0.92


BioIsosteres


EON DESPAIR<br />

• Enrichment in Virtual Screening<br />

• Comparing molecules of different charge<br />

• It’s SO slow (That’s why it’s called EON!)


EON Despair


EON Downright Despondent


• A Miracle worker<br />

• Pharmacophores<br />

• “Cressett”<br />

What EON Isn’t


H<br />

Ligand Tautomers/pKa<br />

H<br />

H


Why single structure-EON might fail:2<br />

Ligand 1<br />

Protein


Why single structure-EON might fail:2<br />

Ligand 2<br />

Protein


Potential distribution mismatch<br />

Ligand 1<br />

Ligand 2


Why single structure-EON might fail:3<br />

Suppressed by


Why single structure-EON might fail:3<br />

Suppression<br />

removed


Why single structure-EON might fail:3<br />

Ligand 1<br />

Protein<br />

Suppression<br />

reinforced


Why single structure-EON might fail:4<br />

“mobile hydrogens”- Serine, Tyrosine<br />

H<br />

Ligand 1<br />

Protein


Why single structure-EON might fail:4<br />

H<br />

Ligand 2<br />

Protein


Natural Failures<br />

• Ligand Tautomer/pKa<br />

• Through-space effects<br />

– Alternate interaction sites<br />

• Charge suppression<br />

– Protein pKa variation<br />

• Rotatable protons<br />

– SER, TYR


EON vs. Pharmacophores<br />

• Single pharmacophore model has exactly the same<br />

issues<br />

• Multiple models-<br />

– Weighting of pharmacophores<br />

• Single pharmacophore model<br />

– Partial matches


EON is not Cresset<br />

• Cresset use fields to<br />

find pharmacophores<br />

• Requires very good<br />

charges (QM level)<br />

• Alignment is point<br />

based/ clique detect<br />

• Probably good (and<br />

faster) for screening<br />

• In EON the field is the<br />

pharmacophore<br />

• Seems to work with<br />

force-field level charges<br />

• Alignment is volumebased/<br />

ROCS-based<br />

• Care and attention when<br />

used for screening.<br />

Shape and color the<br />

appropriate comparison


Multiple Shape Models<br />

Shape Set 1<br />

Shape Set 3<br />

Shape Set 2


Multiple Shape and <strong>Electrostatic</strong><br />

Shape Set 1<br />

Models<br />

Shape & Electro Set 1<br />

Shape & Electro Set 2<br />

Shape & Electro Set 3


Example of Good EON


EON: Database searching, DHFR<br />

• Pre-screen w/ROCS<br />

– S.T. > 0.75<br />

– 8100 -> 315 hits<br />

• Rank by E.T.


2dsim = 0.58<br />

Great Lead Hop<br />

Rank(ST) = 173/315<br />

Rank(ET) = 34/315


EON Happiness<br />

• First find good shapes<br />

• Rerank within good shapes<br />

• Pareto ranking/ harmonic averaging<br />

• Don’t expect great ‘enrichment’<br />

– <strong>Electrostatic</strong> information degrades rapidly with shape<br />

mismatch


Charged Molecules & EON<br />

• The overlap of monopole fields is not formally<br />

convergent!<br />

• Distant Monopoles dominate Local Dipoles


Convergence<br />

[ ]<br />

!<br />

"<br />

"<br />

"<br />

"<br />

#<br />

#<br />

#<br />

###<br />

###<br />

dr<br />

dr<br />

r<br />

r<br />

r<br />

then<br />

r<br />

r<br />

if<br />

dr<br />

r<br />

r<br />

r<br />

d<br />

drd<br />

r<br />

r<br />

r<br />

dxdydz<br />

r<br />

r<br />

2<br />

2<br />

1<br />

2<br />

,<br />

1<br />

2<br />

2<br />

1<br />

2<br />

2<br />

1<br />

2<br />

1<br />

)<br />

(<br />

)<br />

(<br />

1<br />

)<br />

(<br />

)<br />

(<br />

)<br />

(<br />

)<br />

sin(<br />

)<br />

(<br />

)<br />

(<br />

)<br />

(<br />

)<br />

(<br />

$<br />

$<br />

$<br />

$<br />

$<br />

%<br />

&<br />

&<br />

$<br />

$<br />

$<br />

$<br />

L<br />

K<br />

1<br />

/<br />

0<br />

)<br />

,<br />

(<br />

)<br />

,<br />

(<br />

)<br />

,<br />

(<br />

)<br />

,<br />

(<br />

!<br />

"<br />

+ B<br />

A<br />

Overlap<br />

B<br />

B<br />

Overlap<br />

A<br />

A<br />

Overlap<br />

B<br />

A<br />

Overlap


Solvent Boundary Effect:<br />

Charge-Charged, Charged-Neutral, Neutral-Neutral<br />

1<br />

0.9<br />

0.8<br />

0.7<br />

0.6<br />

0.5<br />

0.4<br />

0.3<br />

0.2<br />

0.1<br />

0<br />

5 10 15 20 25 30<br />

crg-crg1<br />

crg-crg2<br />

crg-neu1<br />

crg-neu2<br />

neu-neu1<br />

neu-neu2


Neutral<br />

Thermolysin Inhibitors<br />

Charged


ET(-2)<br />

0.52<br />

0.53<br />

0.54<br />

0.02<br />

0.01<br />

-0.26<br />

0.03<br />

Thermolysin Ligands: H 2 0<br />

ET(-1)<br />

0.64<br />

0.54<br />

0.76<br />

0.11<br />

0.06<br />

-0.30<br />

0.10


650 <strong>Electrostatic</strong> Tanimotos:<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.1 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1<br />

-0.2<br />

Uncharged<br />

Mind The Gap!<br />

Charged


Potential Improvements<br />

• Scaled Tanimotos<br />

• Vector (E) Tanimoto<br />

• “You could say the magic ingredient is..”<br />

– (Marge Simpson, “The Simpsons: Lisa the Vegetarian”,<br />

15 th October, 1995)


Scaled Tanimoto


650 Scaled <strong>Electrostatic</strong> Tanimotos:<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2<br />

y = 2.4025x + 0.0026<br />

R 2 = 0.9808<br />

y = 1.0005x - 0.0001<br />

R 2 = 1<br />

-0.2 0 0.2 0.4 0.6 0.8 1


650 Scaled <strong>Electrostatic</strong> Tanimotos:<br />

Neutral Target, Charged + Neutral Queries<br />

Scaled <strong>Electrostatic</strong> Tanimoto<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

Charged<br />

Unscaled <strong>Electrostatic</strong> Tanimoto


Vector Field Tanimotos<br />

• Monopoles die off as 1/r 2 , (Dipoles as 1/r 3 )<br />

– Don’t dominate long range<br />

– Formally convergent overlap functions<br />

• More variation between molecules<br />

– Lower Tanimotos


0.35<br />

0.3<br />

0.25<br />

0.2<br />

0.15<br />

0.1<br />

0.05<br />

-0.05<br />

-0.1<br />

-0.15<br />

-0.2<br />

Solvent Boundary Effect:<br />

Vector Field Tanimoto<br />

0<br />

0 5 10 15 20 25 30 35<br />

crg-crg1<br />

crg-crg2<br />

crg-neu1<br />

crg-neu2<br />

neu-neu1<br />

neu-neu2


650 Field <strong>Electrostatic</strong> Tanimotos:<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

Uncharged<br />

Charged


650 Field <strong>Electrostatic</strong> Tanimotos:<br />

Neutral Target, Charged + Neutral Queries<br />

Field Tanimoto<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2<br />

y = 0.4139x + 0.029<br />

R 2 = 0.8629<br />

-0.4 -0.2 0 0.2 0.4 0.6 0.8 1<br />

Potential Tanimoto


The extra ingredient is..<br />

• The ‘B’ in ‘PB’<br />

..Salt!<br />

• Models mobile ions as a continuum<br />

• Linear & Non-Linear versions<br />

• Mimic mobile charges in active sites?


650 <strong>Electrostatic</strong> Tanimotos+80mM Salt:<br />

Neutral Target, Charged + Neutral Queries<br />

Salted <strong>Electrostatic</strong> Tanimoto<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2<br />

y = 0.6302x + 0.0241<br />

R 2 = 0.9477<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

<strong>Electrostatic</strong> Tanimoto


650 <strong>Electrostatic</strong> Tanimotos+80mM Salt:<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2


650 Salt <strong>Electrostatic</strong> Tanimotos<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

40mM<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

80mM<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

120mM


Effects of Salt on Potentials:<br />

Differential Charge Placement, +1/-1 kT contours<br />

Formal<br />

charge<br />

No<br />

Salt<br />

ET=0.68<br />

0.04mM 30mM 0.08mM<br />

90mM<br />

ET=0.29 ET=0.22<br />

ET=0.029 ET=0.05


ET(-2)<br />

0.17<br />

0.16<br />

0.21<br />

0.14<br />

0.08<br />

-0.15<br />

0.13<br />

Thermolysin Ligands: Brine<br />

ET(-1)<br />

0.15<br />

0.02<br />

0.32<br />

0.32<br />

0.18<br />

-0.18<br />

0.26


Schnecke & Boström, 2006<br />

Cilomilast vs. Piclamilast


Saving Boström!<br />

ET=0.02<br />

ET=0.11


Are Active Sites Salty?<br />

• Dielectrics are about reorientation of<br />

dipoles<br />

• Ionic environments are about the migration<br />

of charges, e.g. protons.<br />

• I.e. maybe we are supposed to be using salt<br />

in EON comparisons!


EON: definition<br />

Conclusions<br />

1. An immeasurably long period of time<br />

2. A divine power or nature emanating from the<br />

Supreme Being and playing various roles in<br />

the operation of the universe

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!